美国 · SEC FORM 4
ACCURAY INC
ARAY · Nasdaq · CIK 0001138723 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
2 同一窗口内观察到的 Form 4 交易行
0 sales · 2 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-02-20 · MAYER STEVEN F.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -2.5%
- 3M
- -2.5%
- 6M
- -29.6%
- 12M
- -85.2%
波动率与流动性
- 波动率
- 92.0%
- Beta
- 1.42
- 平均每日成交额
- USD 1.8M
估值
- 市值
- USD 30.3M
- P/E
- —
基本面
- 利润率
- -12.2%
- ROE
- -118.0%
- 细分行业
- Medical Devices
市场数据
价格数据截至：2026-10-07 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2026-06-30 · 来自 Yahoo Finance：市值 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,388,578
- 上期报告
- 4,940,266
- 日均成交量
- 35,220,400
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-02-20 | MAYER STEVEN F | 买入 (P) | Common Stock | 54,875 | USD 0.56 | USD 30,730 | SEC 申报 ↗ |
| 2026-02-19 | MAYER STEVEN F | 买入 (P) | Common Stock | 69,000 | USD 0.53 | USD 36,570 | SEC 申报 ↗ |
| 2026-02-18 | MAYER STEVEN F | 买入 (P) | Common Stock | 126,125 | USD 0.53 | USD 66,846 | SEC 申报 ↗ |
| 2025-11-19 | La Neve Stephen R. | 买入 (P) | Common Stock | 20,000 | USD 0.97 | USD 19,400 | SEC 申报 ↗ |
| 2025-06-13 | WHITTERS JOSEPH E | 买入 (P) | Common Stock | 50,000 | USD 1.25 | USD 62,500 | SEC 申报 ↗ |
| 2024-05-29 | WHITTERS JOSEPH E | 买入 (P) | Common Stock | 50,000 | USD 1.58 | USD 79,000 | SEC 申报 ↗ |
| 2024-05-28 | WHITTERS JOSEPH E | 买入 (P) | Common Stock | 50,000 | USD 1.54 | USD 77,000 | SEC 申报 ↗ |
| 2022-01-31 | Winter Suzanne C | 买入 (P) | Common Stock | 761 | USD 3.53 | USD 2,686 | SEC 申报 ↗ |
| 2022-01-31 | Winter Suzanne C | 买入 (P) | Common Stock | 11,239 | USD 3.53 | USD 39,674 | SEC 申报 ↗ |
| 2021-11-08 | Scott Byron C | 买入 (P) | Common Stock | 9,000 | USD 5.45 | USD 49,050 | SEC 申报 ↗ |
| 2021-08-18 | Scott Byron C | 买入 (P) | Common Stock | 10,000 | USD 3.65 | USD 36,500 | SEC 申报 ↗ |
| 2021-08-18 | LEVINE JOSHUA | 买入 (P) | Common Stock | 15,000 | USD 3.63 | USD 54,387 | SEC 申报 ↗ |
| 2021-08-16 | WHITTERS JOSEPH E | 买入 (P) | Common Stock | 17,500 | USD 3.64 | USD 63,700 | SEC 申报 ↗ |
| 2021-02-01 | WHITTERS JOSEPH E | 买入 (P) | Common Stock | 20,000 | USD 5.02 | USD 100,400 | SEC 申报 ↗ |
| 2020-11-11 | WHITTERS JOSEPH E | 买入 (P) | Common Stock | 50,000 | USD 3.46 | USD 173,000 | SEC 申报 ↗ |
Form 4 申报证据
29 transaction lines in the latest 365-day window; 198 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Pervaiz Ali | 代扣税 (F) | Common Stock | 8,915 | USD 0.23 | USD 2,010 | SEC 申报 ↗ |
| 2026-09-23 | Pervaiz Ali | 奖励／授予 (A) | Common Stock | 19,811 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-28 | Peralta Leonel | 期权行权／转换 (M) | Common Stock | 83,723 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (29 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Pervaiz Ali | 代扣税 (F) | Common Stock | 8,915 | USD 0.23 | USD 2,010 | SEC 申报 ↗ |
| 2026-09-23 | Pervaiz Ali | 奖励／授予 (A) | Common Stock | 19,811 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-28 | Peralta Leonel | 期权行权／转换 (M) | Common Stock | 83,723 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-28 | Peralta Leonel | 代扣税 (F) | Common Stock | 28,969 | USD 0.55 | USD 15,933 | SEC 申报 ↗ |
| 2026-02-20 | MAYER STEVEN F | 买入 (P) | Common Stock | 54,875 | USD 0.56 | USD 30,730 | SEC 申报 ↗ |
| 2026-02-19 | MAYER STEVEN F | 买入 (P) | Common Stock | 69,000 | USD 0.53 | USD 36,570 | SEC 申报 ↗ |
| 2026-02-18 | MAYER STEVEN F | 买入 (P) | Common Stock | 126,125 | USD 0.53 | USD 66,846 | SEC 申报 ↗ |
| 2025-12-31 | Scott Byron C | 期权行权／转换 (M) | Common Stock | 9,433 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-31 | Scott Byron C | 代扣税 (F) | Common Stock | 3,774 | USD 0.82 | USD 3,095 | SEC 申报 ↗ |
| 2025-12-01 | Pervaiz Ali | 代扣税 (F) | Common Stock | 57,341 | USD 1.02 | USD 58,488 | SEC 申报 ↗ |
| 2025-12-01 | Chalke Sandeep | 代扣税 (F) | Common Stock | 64,477 | USD 1.02 | USD 65,767 | SEC 申报 ↗ |
| 2025-11-29 | Pervaiz Ali | 期权行权／转换 (M) | Common Stock | 44,025 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-29 | Chalke Sandeep | 期权行权／转换 (M) | Common Stock | 50,314 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-28 | MAYER STEVEN F | 奖励／授予 (A) | Common Stock | 895,391 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-28 | Galbato Chan | 奖励／授予 (A) | Common Stock | 50,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | WHITTERS JOSEPH E | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | Scott Byron C | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | Scott Byron C | 代扣税 (F) | Common Stock | 22,642 | USD 1.05 | USD 23,774 | SEC 申报 ↗ |
| 2025-11-21 | Nishimura Mika | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | MAYER STEVEN F | 期权行权／转换 (M) | Common Stock | 45,620 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | Le Grand Anne Bryce | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | Hindman James M. | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | HUSS BEVERLY A | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-21 | HUSS BEVERLY A | 代扣税 (F) | Common Stock | 22,642 | USD 1.05 | USD 23,774 | SEC 申报 ↗ |
| 2025-11-19 | La Neve Stephen R. | 买入 (P) | Common Stock | 20,000 | USD 0.97 | USD 19,400 | SEC 申报 ↗ |
| 2025-11-13 | Kill Robert | 期权行权／转换 (M) | Common Stock | 56,603 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-10-31 | MURPHY MICHAEL JOHN | 期权行权／转换 (M) | Common Stock | 37,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-10-31 | MURPHY MICHAEL JOHN | 代扣税 (F) | Common Stock | 12,001 | USD 1.41 | USD 16,921 | SEC 申报 ↗ |
| 2025-10-31 | MAYER STEVEN F | 奖励／授予 (A) | Common Stock | 354,609 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ARAY |
| CIK | 0001138723 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 198 transaction lines from 2020-01-03 to 2026-09-23 16 P purchase lines · 62 S sale lines · 120 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.